Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Ewa Kucewicz"'
Publikováno v:
Polish Journal of Thoracic and Cardiovascular Surgery, Vol 21, Iss 2, Pp 96-98 (2024)
Angiotensin II (AT) is a potent vasoconstrictor and hypertensive drug that is registered for the treatment of severe hypotension in vasoplegic shock. Growing experience with the use of AT in cardiac surgery allows the first therapeutic algorithms to
Externí odkaz:
https://doaj.org/article/ac32784d06d24fc7a207bdf286501457
Publikováno v:
Anaesthesiology Intensive Therapy, Vol 54, Iss 3, Pp 279-284 (2022)
The debate about medical futility often involves intensive care units where life-support procedures are routinely applied. Futile therapy is part of end-of-life therapy. In the discussion about medical futility it is important to distinguish the effe
Externí odkaz:
https://doaj.org/article/70517c94c5f042b68a966bfe91a154c8
Autor:
Ewa Kucewicz-Czech, Leszek Machej, Kazimierz Kiermasz, Andrzej Węglarzy, Maria Damps, Damian Hudziak, Radosław Gocol, Andrzej Ochała, Radosław Parma
Publikováno v:
Polish Journal of Thoracic and Cardiovascular Surgery, Vol 17, Iss 4, Pp 198-202 (2021)
Externí odkaz:
https://doaj.org/article/87d753791ed5421d81239eef52725998
Autor:
Ewa Kucewicz-Czech, Maria Damps
Publikováno v:
Anaesthesiology Intensive Therapy, Vol 52, Iss 4, Pp 312-315 (2020)
The coronavirus disease (COVID-19) was previously unknown, and we are learning about it day by day, but pandemic-associated ethical dilemmas have been studied and discussed for years. Triage means not only ranking in terms of importance (prioritisati
Externí odkaz:
https://doaj.org/article/fdbf9b7c6cd64a5bbcbfd9025ead333e
Publikováno v:
Biomedicines, Vol 11, Iss 4, p 1224 (2023)
The present study aimed to assess the changes in the immunological parameters of patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). The serum or plasma samples of patients were assessed to determine the concentrations of IL-6, one
Externí odkaz:
https://doaj.org/article/2b41fbbcaa394c049a12aa2df5eb8194
Autor:
Tomasz Maciejewski, Tomasz Darocha, Kazimierz Kiermasz, Barbara Budziarz, Piotr Duraj, Wojciech Szanecki, Mirosława Mackiewicz, Jarosław Myszor, Katarzyna Mizia-Stec, Ewa Kucewicz-Czech
Publikováno v:
Anaesthesiology Intensive Therapy, Vol 51, Iss 1, Pp 73-79 (2019)
Externí odkaz:
https://doaj.org/article/e7dcc9e953894f50b28e99ac861cab57
Autor:
Maria Damps, Ludwik Stołtny, Jadwiga Siemek-Mitela, Andrzej Lekstan, Łukasz Krzych, Ewa Kucewicz-Czech
Publikováno v:
Anaesthesiology Intensive Therapy, Vol 51, Iss 4, Pp 262-267 (2019)
Externí odkaz:
https://doaj.org/article/ec53ef2a761e4969af73da5cb78bc9e1
Autor:
Tadeusz Kołodziej, Tomasz Maciejewski, Konrad Mendrala, Tomasz Darocha, Andrzej Węglarzy, Barbara Budziarz, Kazimierz Kiermasz, Ewa Kucewicz-Czech
Publikováno v:
Polish Journal of Thoracic and Cardiovascular Surgery, Vol 16, Iss 1, Pp 32-36 (2019)
The concept of early recovery after surgery (ERAS) consists of bundle interventions during the pre-, intra- and postoperative periods and team work. The ERAS, which is a multimodal strategy, enables one to limit the neurohumoral response to the surge
Externí odkaz:
https://doaj.org/article/c90390b227ba49c8824e07dfcb83f4cc
Autor:
Maria Damps, Kazimierz Kiermasz, Radosław Parma, Radosław Gocoł, Andrzej Ochała, Leszek Machej, Ewa Kucewicz-Czech, Damian Hudziak, Andrzej Węglarzy
Publikováno v:
Kardiochirurgia i Torakochirurgia Polska = Polish Journal of Cardio-Thoracic Surgery
Polish Journal of Thoracic and Cardiovascular Surgery, Vol 17, Iss 4, Pp 198-202 (2021)
Polish Journal of Thoracic and Cardiovascular Surgery, Vol 17, Iss 4, Pp 198-202 (2021)
Introduction Over the last two decades transcatheter aortic valve replacement (TAVR) has been approved for clinical use. The anaesthetic choice for this procedure is evolving. General anaesthesia was the predominant anaesthetic technique. Growing exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aa5bed24e25d0735eed7337cefc7f20
http://europepmc.org/articles/PMC7848612
http://europepmc.org/articles/PMC7848612
Autor:
Robert Zymliński, Katarzyna Wilk, Agnieszka Tycińska, Jacek Kubica, Jarosław Bugajski, Ewa Straburzyńska-Migaj, Marek A. Deja, Grzegorz Grześk, Ewa Kucewicz-Czech, Marcin Gruchała, Joanna Płonka, Barbara Zawiślak, Przemysław Leszek, Rafał Depukat, Jarosław D. Kasprzak, Marek Gierlotka, Bożena Sobkowicz, Janina Stępińska
Publikováno v:
Kardiologia Polska. 78:825-834
Levosimendan is a new inodilator which involves 3 main mechanisms: increases the calcium sensitivity of cardiomyocytes, acts as a vasodilator due to the opening of potassium channels, and has a cardioprotective effect. Levosimendan is mainly used in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb6fb21f5130cda9dfe7c626dd0c0a6d
https://doi.org/10.33963/kp.15551
https://doi.org/10.33963/kp.15551